Rocket One RKTO
NASDAQ RKTO
$0.67 -0.03 (-4.40%)
At close: Sep 9, 2026 · 4:00 PM EDT

Rocket One (RKTO) Net Equity Issued and Repurchased (2019 - 2026)

Rocket One's (RKTO) quarterly Net Equity Issued and Repurchased came in at $5.1 million in Q2 2026, up 7684.42% year-over-year from $66101.0 in Q2 2025, and up 633.53% quarter-over-quarter from $701484.0 in Q1 2026.

Analysis

Rocket One (RKTO) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends

Rocket One has disclosed Net Equity Issued and Repurchased across 6 years of filings, most recently posting $5.1 million for Q2 2026.

  • In Q2 2026, Net Equity Issued and Repurchased rose 7684.42% year-over-year to $5.1 million; the TTM figure through Jun 2026 stood at $8.5 million (up 229.22% YoY), while the FY2025 annual figure was $4.1 million, up 288.31% from the prior year.
  • Net Equity Issued and Repurchased came in at $5.1 million for Q2 2026 at Rocket One, up from $701484.0 in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $5.1 million in Q2 2026 to a low of $66101.0 in Q2 2025.
  • Average Net Equity Issued and Repurchased over 4 years is $1.7 million, with a median of $1.3 million recorded in 2024.
  • The largest YoY upside for Net Equity Issued and Repurchased was 7684.42% in 2026 against a maximum downside of 51.35% in 2026.
  • Over 4 years, Net Equity Issued and Repurchased stood at $2.4 million in 2023, then sank by 55.89% to $1.1 million in 2024, then tumbled by 42.76% to $607309.0 in 2025, then surged by 747.28% to $5.1 million in 2026.
  • Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $5.1 million in Q2 2026, $701484.0 in Q1 2026, and $607309.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn -
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 9.00 Mn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 49.20 Mn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn -
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -
10 Rocket One 13.86 Mn 5.97 Mn - 5.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.15 Mn
Mar 31, 2026 701,484.00
Dec 31, 2025 607,309.00
Sep 30, 2025 2.00 Mn
Jun 30, 2025 66,101.00
Mar 31, 2025 1.44 Mn
Dec 31, 2024 1.06 Mn
Sep 30, 2023 2.41 Mn
Jun 30, 2021 -137,500.00
Mar 31, 2021 4.57 Mn
Sep 30, 2019 -1.00
Jun 30, 2019 -17,332.00
Mar 31, 2019 5.86 Mn